EPIX
Price
$1.60
Change
+$0.03 (+1.90%)
Updated
Apr 3, 03:21 PM (EDT)
Capitalization
70.13M
40 days until earnings call
MREO
Price
$2.27
Change
-$0.09 (-3.80%)
Updated
Apr 3, 02:49 PM (EDT)
Capitalization
376.83M
41 days until earnings call
Ad is loading...

EPIX vs MREO

Header iconEPIX vs MREO Comparison
Open Charts EPIX vs MREOBanner chart's image
ESSA Pharma
Price$1.60
Change+$0.03 (+1.90%)
Volume$350
Capitalization70.13M
Mereo BioPharma Group
Price$2.27
Change-$0.09 (-3.80%)
Volume$819
Capitalization376.83M
EPIX vs MREO Comparison Chart
Loading...
EPIX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MREO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
EPIX vs. MREO commentary
Apr 03, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EPIX is a StrongBuy and MREO is a Buy.

Ad is loading...
COMPARISON
Comparison
Apr 03, 2025
Stock price -- (EPIX: $1.58 vs. MREO: $2.37)
Brand notoriety: EPIX and MREO are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: EPIX: 42% vs. MREO: 129%
Market capitalization -- EPIX: $70.13M vs. MREO: $376.83M
EPIX [@Biotechnology] is valued at $70.13M. MREO’s [@Biotechnology] market capitalization is $376.83M. The market cap for tickers in the [@Biotechnology] industry ranges from $308.32B to $0. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

EPIX’s FA Score shows that 1 FA rating(s) are green whileMREO’s FA Score has 1 green FA rating(s).

  • EPIX’s FA Score: 1 green, 4 red.
  • MREO’s FA Score: 1 green, 4 red.
According to our system of comparison, both EPIX and MREO are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

EPIX’s TA Score shows that 5 TA indicator(s) are bullish while MREO’s TA Score has 4 bullish TA indicator(s).

  • EPIX’s TA Score: 5 bullish, 3 bearish.
  • MREO’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, EPIX is a better buy in the short-term than MREO.

Price Growth

EPIX (@Biotechnology) experienced а +3.27% price change this week, while MREO (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -8.22%. For the same industry, the average monthly price growth was -10.33%, and the average quarterly price growth was -14.34%.

Reported Earning Dates

EPIX is expected to report earnings on May 13, 2025.

MREO is expected to report earnings on May 14, 2025.

Industries' Descriptions

@Biotechnology (-8.22% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MREO($377M) has a higher market cap than EPIX($70.1M). EPIX YTD gains are higher at: -11.732 vs. MREO (-32.286). EPIX has higher annual earnings (EBITDA): -30.57M vs. MREO (-43.41M). EPIX has more cash in the bank: 120M vs. MREO (80.5M). EPIX has less debt than MREO: EPIX (305K) vs MREO (6.68M). MREO has higher revenues than EPIX: MREO (1M) vs EPIX (0).
EPIXMREOEPIX / MREO
Capitalization70.1M377M19%
EBITDA-30.57M-43.41M70%
Gain YTD-11.732-32.28636%
P/E RatioN/AN/A-
Revenue01M-
Total Cash120M80.5M149%
Total Debt305K6.68M5%
FUNDAMENTALS RATINGS
EPIX vs MREO: Fundamental Ratings
EPIX
MREO
OUTLOOK RATING
1..100
213
VALUATION
overvalued / fair valued / undervalued
1..100
16
Undervalued
77
Overvalued
PROFIT vs RISK RATING
1..100
10081
SMR RATING
1..100
9598
PRICE GROWTH RATING
1..100
9089
P/E GROWTH RATING
1..100
1002
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

EPIX's Valuation (16) in the Pharmaceuticals Major industry is somewhat better than the same rating for MREO (77) in the null industry. This means that EPIX’s stock grew somewhat faster than MREO’s over the last 12 months.

MREO's Profit vs Risk Rating (81) in the null industry is in the same range as EPIX (100) in the Pharmaceuticals Major industry. This means that MREO’s stock grew similarly to EPIX’s over the last 12 months.

EPIX's SMR Rating (95) in the Pharmaceuticals Major industry is in the same range as MREO (98) in the null industry. This means that EPIX’s stock grew similarly to MREO’s over the last 12 months.

MREO's Price Growth Rating (89) in the null industry is in the same range as EPIX (90) in the Pharmaceuticals Major industry. This means that MREO’s stock grew similarly to EPIX’s over the last 12 months.

MREO's P/E Growth Rating (2) in the null industry is significantly better than the same rating for EPIX (100) in the Pharmaceuticals Major industry. This means that MREO’s stock grew significantly faster than EPIX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
EPIXMREO
RSI
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
85%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
83%
Momentum
ODDS (%)
Bearish Trend 3 days ago
85%
Bearish Trend 2 days ago
87%
MACD
ODDS (%)
Bullish Trend 2 days ago
86%
Bearish Trend 2 days ago
87%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
80%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
81%
Advances
ODDS (%)
Bullish Trend 4 days ago
84%
Bullish Trend 8 days ago
81%
Declines
ODDS (%)
Bearish Trend 9 days ago
87%
Bearish Trend 3 days ago
87%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
86%
View a ticker or compare two or three
Ad is loading...
EPIX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MREO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GSTSX9.06N/A
N/A
Goldman Sachs Strategic Growth Svc
DQIRX29.79N/A
N/A
BNY Mellon Equity Income Fund I
GTENX45.17N/A
N/A
Gateway N
WQAIX11.32N/A
N/A
Westwood Quality AllCap Institutional
RAZAX10.70-0.06
-0.56%
Russell Inv Multi-Asset Strat A

MREO and

Correlation & Price change

A.I.dvisor indicates that over the last year, MREO has been loosely correlated with VKTX. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if MREO jumps, then VKTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MREO
1D Price
Change %
MREO100%
+9.22%
VKTX - MREO
40%
Loosely correlated
+7.40%
TERN - MREO
39%
Loosely correlated
-2.73%
TRDA - MREO
38%
Loosely correlated
+0.46%
INZY - MREO
37%
Loosely correlated
+6.48%
MDGL - MREO
37%
Loosely correlated
+3.28%
More